Stephen G. Machatha
2021
In 2021, Stephen G. Machatha earned a total compensation of $1.4M as Chief Development Officer at Aldeyra Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $133,429 |
|---|---|
| Option Awards | $953,016 |
| Salary | $333,572 |
| Other | $11,400 |
| Total | $1,431,416 |
Machatha received $953K in option awards, accounting for 67% of the total pay in 2021.
Machatha also received $133.4K in non-equity incentive plan, $333.6K in salary and $11.4K in other compensation.
Rankings
In 2021, Stephen G. Machatha's compensation ranked 7,449th out of 12,415 executives tracked by ExecPay. In other words, Machatha earned more than 40.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,449 out of 12,415 | 40th |
Division Manufacturing | 3,276 out of 5,505 | 41st |
Major group Chemicals And Allied Products | 1,449 out of 2,375 | 39th |
Industry group Drugs | 1,290 out of 2,096 | 39th |
Industry Pharmaceutical Preparations | 948 out of 1,546 | 39th |
Source: SEC filing on April 25, 2022.
Machatha's colleagues
We found two more compensation records of executives who worked with Stephen G. Machatha at Aldeyra Therapeutics in 2021.